Showing results (81-90 of 174) with videos related to
Sort By:
Pageof 18
Annals of the New York Academy of Sciences|June 17, 2005
Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia veraUlrich Steidl, Thomas Schroeder, Christian Steidl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter studyGeorg Hess, Donald Bunjes, Wolfgang Siegert, et al.Oncogene|April 5, 2005
Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemiaRalf Kronenwett, Ulf Butterweck, Ulrich Steidl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCharalampia Kyriakou, Carmen Canals, Anthony Goldstone, et al.British Journal of Haematology|January 28, 2012
Risk models predicting survival after reduced-intensity transplantation for myelofibrosisHaefaa Alchalby, Dinah-Rohina Yunus, Tatjana Zabelina, et al.Sensors (Basel, Switzerland)|September 30, 2020
Reliable Detection of Atrial Fibrillation with a Medical Wearable during Inpatient ConditionsMalte Jacobsen, Till A Dembek, Athanasios-Panagiotis Ziakos, et al.Blood|May 22, 2010
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosisHaefaa Alchalby, Anita Badbaran, Tatjana Zabelina, et al.Leukemia Research|May 14, 2021
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral centerKathrin Nachtkamp, Josefine Stark, Andrea Kündgen, et al.Bone Marrow Transplantation|August 18, 2022
Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trialJürgen Finke, Claudia Schmoor, Matthias Stelljes, et al.Cancers|June 19, 2024
Overlapping Stromal Alterations in Myeloid and Lymphoid NeoplasmsLucienne Bogun, Annemarie Koch, Bo Scherer, et al.Pageof 18